AVIVA Biosciences

AVIVA Biosciences Developers of RedSift technology for WBC & rare cell isolation.We are also a CRO specializing in ion channel screening for preclinical drug candidates.

07/07/2016

The greatest catalyst for the cloning of Dolly the sheep was a conversation in a Dublin bar.

We learn more about CTCs (circulating tumor cells) everyday. PM us for more information on   and   assays!
07/06/2016

We learn more about CTCs (circulating tumor cells) everyday. PM us for more information on and assays!

We are at City of Hope Medical Center today to present our RedSift cell enrichment technology. Join us in the Cooper Aud...
06/28/2016

We are at City of Hope Medical Center today to present our RedSift cell enrichment technology. Join us in the Cooper Auditorium from 11-1:30.

Join us at the City of Hope Medical Center in Duarte, CA to discuss cell enrichment, CTCs, and other applications of the...
06/21/2016

Join us at the City of Hope Medical Center in Duarte, CA to discuss cell enrichment, CTCs, and other applications of the RedSift Cell Processor. We will be in Cooper Auditorium from 11:30-1:30 and on campus for the remainder of the day.

Retweeted Kyle Bradley, MD ():Metastatic melanoma in lymph node sinuses.   https://t.co/h8V0PEiwVl
05/16/2016

Retweeted Kyle Bradley, MD ():

Metastatic melanoma in lymph node sinuses. https://t.co/h8V0PEiwVl

Get the whole picture - and other photos from Kyle Bradley, MD

Retweeted Cancer Cytopathology ():The May 2016 issue of Cancer Cytopathology is live! https://t.co/51jkrzOOAt
05/16/2016

Retweeted Cancer Cytopathology ():

The May 2016 issue of Cancer Cytopathology is live! https://t.co/51jkrzOOAt

The category of atypical urothelial cell has to date been an equivocal diagnostic category, causing frustration to both cytopathologists and clinicians. The new Paris System for Reporting Urinary Cytology now offers well-defined criteria that will help to standardize this problematic category as wel...

Ficoll and lysis protocols retrieve ~60% of cells (on a good day). RedSift = 97%.
05/16/2016

Ficoll and lysis protocols retrieve ~60% of cells (on a good day). RedSift = 97%.

05/12/2016

A Convenient & Effective Strategy for the Enrichment of Tumor-Initiating Cell Properties in Cells
https://t.co/8rOzxd09xc

Stem-like prostate cancer (PrCa) cells, also called PrCa stem cells (PrCSCs) or PrCa tumor-initiating cells (PrTICs), are considered to be involved in the mediation of tumor metastasis and may be responsible for the poor prognosis of PrCa patients. Currently, the methods for PrTIC sorting are mainly...

We've got several copies of our poster at Booth 2739 and a full demo running for  . Come by to discuss CTC enrichment an...
04/19/2016

We've got several copies of our poster at Booth 2739 and a full demo running for . Come by to discuss CTC enrichment and isolation!

We are presenting our poster in section 18 today to discuss automated recovery of circulating tumor cells. Check it out!...
04/17/2016

We are presenting our poster in section 18 today to discuss automated recovery of circulating tumor cells. Check it out!

Our   promo begins tomorrow! If you're seeing this photo, you're already one step closer to winning!
04/15/2016

Our promo begins tomorrow! If you're seeing this photo, you're already one step closer to winning!

Address

San Diego, CA
92121

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Alerts

Be the first to know and let us send you an email when AVIVA Biosciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to AVIVA Biosciences:

Featured

Share